Moreover, CYP up-regulation has been recently shown to play a key role in the advancement of steatotic liver to the non-alcoholic steatohepatitis (NASH), as well as insulin resistance development [23]. The gene discussed is PPIG; the disease is metabolic dysfunction-associated steatohepatitis.